Health
US FDA orders vision-loss warning on all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound
The US drug regulator has ordered a new vision-loss warning on all GLP-1 weight-loss and diabetes drugs, after a review of trial data found a small number of cases of a rare eye condition.